Natco Pharma Ltd
Natco Pharma's GHG Emissions Data Preview
In 2023, Natco Pharma completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), and Scope 2 (indirect emissions from purchased energy).
However, Natco Pharma has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.
| Metric (tCO2e) | 2024 | 2023 | 2022 | 2021 - 2017 |
|---|---|---|---|---|
Total Scope 1 | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
Total Scope 2 | ||||
Unspecified Calculation Method | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
Total Scope 3 | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data. | 0000000 |
This table provides a simplified preview of selected GHG emissions data points. To access the complete dataset with full disclosures, detailed breakdowns, and source traceability, create a free account to view purchase options.
Insights into Natco Pharma's Operational Emissions
In 2023, the total operational greenhouse gas (GHG) emissions of Natco Pharma amounted to 68,760 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).
Compared to 2022, the total operational greenhouse gas (GHG) emissions of Natco Pharma increased by 17.65%, suggesting that the company faced challenges in reducing its emissions from its core operations.
Natco Pharma's Scope 1 Emissions Over Time
- Total Scope 1
- Year-over-Year Change
What are Natco Pharma's Scope 1 emissions?
In 2023, the total Scope 1 emissions of Natco Pharma were 24,890 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).
Has Natco Pharma reduced its Scope 1 emissions over time?
Since 2021, Natco Pharma's Scope 1 emissions have increased by 87.64%, reflecting a rising long-term trend in Scope 1 emissions over time.
Compared to the previous year (2022), Natco Pharma's Scope 1 emissions increased by 84.69%, suggesting that the company faced challenges in reducing emissions from its directly owned or controlled operations.
What are Natco Pharma's Scope 2 emissions?
In 2023, Natco Pharma reported Scope 2 greenhouse gas (GHG) emissions of 43,870 tCOâ‚‚e without specifying the calculation method.
Has Natco Pharma reduced its Scope 2 emissions over time?
Since 2021, Natco Pharma's Scope 2 greenhouse gas (GHG) emissions (Unspecified Calculation Method) have remained relatively stable, indicating that Natco Pharma 's emissions have plateaued with no significant change in its energy consumption footprint.
Compared to the previous year (2022), Natco Pharma's Scope 2 emissions (Unspecified Calculation Method) have remained relatively stable, indicating that Natco Pharma 's emissions have plateaued with no significant change in its energy consumption footprint.
What methodology does Natco Pharma use for Scope 2 reporting?
In 2023, Natco Pharma reported its Scope 2 emissions using an unspecified methodology.
Natco Pharma's Scope 2 Emissions Over Time
- Total Scope 2 (Unspecified Calculation Method)